Form 8-K · Current Report · Filed 2025-12-16
Pfizer Provides Full-Year 2026 Guidance and Revises 2025 Revenue Forecast
On December 16, 2025, Pfizer Inc. issued a press release announcing its full-year 2026 revenue guidance of $59.5 to $62.5 billion, with Adjusted diluted EPS expected to range between $2.80 and $3.00. Additionally, Pfizer revised its full-year 2025 revenue guidance to approximately $62.0 billion, while reaffirming all other components of its 2025 financial guidance. A detailed financial outlook and comparison with the previous guidance are available in the furnished press release.
- Filer
- Pfizer Inc. PFE · NYSE
- Filed
- Accession
- 0000078003-25-000167
- CIK
- 0000078003
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$26.43
Next session
-5.3%
Since filing
-5.4%
Latest close
$25.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from PFE reporting the same item, with the next session's move:
About Pfizer Inc.
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.
Never miss another PFE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.